(Q41750558)

8 October 2017

1 reference

title

Fungal infection in the intensive care unit (English)

1 reference

8 October 2017

1 reference

Flanagan PG

1

1 reference

8 October 2017

Barnes RA

series ordinal

2

1 reference

8 October 2017

publication date

1 March 1998

1 reference

Journal of Hospital Infection

8 October 2017

published in

1 reference

8 October 2017

volume

38

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

163-177

1 reference

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Impact of the changing epidemiology of fungal infections in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Candidemia in intensive care unit patients: Risk factors for mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fungal infections in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Azole drug resistance in yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

An outbreak of aspergillosis in a general ITU.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Invasive pulmonary aspergillosis in non-immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Malassezia fungemia in neonates and adults: complication of hyperalimentation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Sepsis due to Rhodotorula related to use of indwelling central venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Pneumocystis carinii: molecular taxonomy and epidemiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fungal infection in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Editorial response: catheters and candidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Hemofiltration: treating and preventing infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Intravenous lipid emulsions and host defense - a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

The effect of glutamine-enriched TPN on gut immune cellularity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Cellular defense in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fungaemia and funguria after oral administration of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Impaired clearance and organ localization of Candida albicans in obstructive jaundice

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Indications for therapy for fungemia in postoperative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Candida colonization and subsequent infections in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Clinical significance of Candida isolated from peritoneum in surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Gallbladder and biliary tract candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Prognostic indicators in fungemia of the surgical patient

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Hazards of inadequate fluconazole dosage to treat deep-seated or systemic Candida albicans infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Should all patients with candidemia be treated with antifungal agents?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Microbiological and clinical evaluation of the isolator lysis-centrifugation blood culture tube.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Clinical comparison of isolator and BACTEC 660 resin media for blood culture

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Limited usefulness of quantitative culture of blood drawn through the device for diagnosis of intravascular-device-related bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Detection of Candida albicans and other yeasts in blood by PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

C-reactive protein as a diagnostic test of sepsis in the critically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

C-reactive protein: A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Candida sepsis. Implications of polymicrobial blood-borne infection

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Administering amphotericin B--a practical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Do the new lipid formulations of amphotericin B really work?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Treatment of Candida albicans fungaemia with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Infectious complications of indwelling vascular catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

Nosocomial acquisition of Candida parapsilosis: an epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-6701%2898%2990271-7

7 January 2021

10.1016/S0195-6701(98)90271-7

Identifiers

DOI

1 reference

8 October 2017

1 reference